Figures & data
Table 1 Demographic and clinical characteristics of HIV patients
Figure 1 Serum glucose levels in HIV-infected patients with or without HAART. HAART group represents HIV patients undergoing HAART; HAART-naive group represents HIV patients without HAART; total group represents all HIV patients; non-dysglycemia; IFG: impaired fasting glucose; DM, diabetes mellitus; GLU, glucose. The horizontal lines represent mean values, the boxes represent standard deviations, and the whiskers represent ranges. *p < 0.05.
Table 2 Glucose metabolic disorders in HIV-1 patients with different HAART regimens
Figure 2 Serum lipid levels in HIV patients with or without HAART. HAART group represents HIV patients undergoing HAART; HAART-naive group represents HIV patients without HAART; total group represents all HIV patients; non-dysglycemia; IFG: impaired fasting glucose; DM, diabetes mellitus; CHOL, cholesterol; TRIG, triglyceride; HDL, high density lipoprotein; VLDL-c, very low-density lipoprotein; LDL-c, low-density lipoprotein. The horizontal lines represent mean values, the boxes represent standard deviations, and the whiskers represent ranges. *p < 0.05.
Figure 3 CD8 + and CD8 + HLA-DR + T cell counts and percentages in HIV patients with or without HAART. HAART group represents HIV patients undergoing HAART; HAART-naive group represents HIV patients without HAART; total group represents all HIV patients; non-dysglycemia; IFG: impaired fasting glucose; DM, diabetes mellitus; HLADR, Human leukocyte antigen-DR (HLA-DR). The horizontal lines represent mean values, the boxes represent standard deviations, and the whiskers represent ranges. *p < 0.05.
